Plain-English translation of NCT07662044 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes Mellitus research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new diabetes medication called to see if it can help adults with type 2 diabetes better control their blood sugar. Researchers are comparing three approaches: by itself, combined with another existing diabetes medication called , and a placebo (a dummy pill with no active medicine). The goal is to find out which approach works best and is safest for patients.
Type 2 diabetes affects millions of people, and many patients struggle to control their blood sugar with lifestyle changes and current medications alone. Researchers are testing this new treatment to see if it offers a better option for people whose diabetes isn't well managed with existing therapies.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll be randomly assigned to take one of four daily pills: two different strengths of the new medication, the new medication combined with the other diabetes drug, or a placebo. You'll take your assigned medication once daily by mouth. Throughout the study, you'll have regular visits with the research team to check your blood sugar, monitor how you're responding to the medication, and watch for any side effects.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States